Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Open Access
- 17 July 2021
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-12
Abstract
Background: Muscle weakness is a complication of critical illness which hampers recovery. In critically ill mice, supplementation with the ketone body 3-hydroxybutyrate has been shown to improve muscle force and to normalize illness-induced hypocholesterolemia. We hypothesized that altered cholesterol homeostasis is involved in development of critical illness-induced muscle weakness and that this pathway can be affected by 3-hydroxybutyrate. Methods: In both human critically ill patients and septic mice, the association between circulating cholesterol concentrations and muscle weakness was assessed. In septic mice, the impact of 3-hydroxybutyrate supplementation on cholesterol homeostasis was evaluated with use of tracer technology and through analysis of markers of cholesterol metabolism and downstream pathways. Results: Serum cholesterol concentrations were lower in weak than in non-weak critically ill patients, and in multivariable analysis adjusting for baseline risk factors, serum cholesterol was inversely correlated with weakness. In septic mice, plasma cholesterol correlated positively with muscle force. In septic mice, exogenous 3-hydroxybutyrate increased plasma cholesterol and altered cholesterol homeostasis, by normalization of plasma mevalonate and elevation of muscular, but not hepatic, expression of cholesterol synthesis genes. In septic mice, tracer technology revealed that 3-hydroxybutyrate was preferentially taken up by muscle and metabolized into cholesterol precursor mevalonate, rather than TCA metabolites. The 3-hydroxybutyrate protection against weakness was not related to ubiquinone or downstream myofiber mitochondrial function, whereas cholesterol content in myofibers was increased. Conclusions: These findings point to a role for low cholesterol in critical illness-induced muscle weakness and to a protective mechanism-of-action for 3-hydroxybutyrate supplementation.Keywords
Funding Information
- H2020 European Research Council (AdvG 2017-785809)
- Fonds Wetenschappelijk Onderzoek (G.0C78.17N, G.0694.21N)
- Vlaamse regering (METH14/06)
This publication has 49 references indexed in Scilit:
- Cholesterol Depletion Uncouples -dystroglycans from Discrete Sarcolemmal Domains, Reducing the Mechanical Activity of Skeletal MuscleCellular Physiology and Biochemistry, 2012
- Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemiaJournal of Lipid Research, 2012
- Critical illness induces alternative activation of M2 macrophages in adipose tissueCritical Care, 2011
- Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shockCritical Care, 2011
- Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trialCritical Care Medicine, 2009
- Adrenal Insufficiency: The Link Between Low Apolipoprotein A-I Levels and Poor Outcome in the Critically Ill?Critical Care Medicine, 2004
- Distribution and Kinetics of Lipoprotein-Bound EndotoxinInfection and Immunity, 2001
- Contribution of acetoacetate to the synthesis of cholesterol and fatty acids in regions of developing rat brain in vivoNeurochemistry International, 1985
- Acetoacetate: a major substrate for the synthesis of cholesterol and fatty acids by isolated rat hepatocytesFEBS Letters, 1983
- Preferential utilization of ketone bodies for the synthesis of myelin cholesterol in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981